Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

Cited In for PubMed (Select 9570524)


The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth.

Ohashi M, Holthaus AM, Calderwood MA, Lai CY, Krastins B, Sarracino D, Johannsen E.

PLoS Pathog. 2015 Apr 9;11(4):e1004822. doi: 10.1371/journal.ppat.1004822. eCollection 2015 Apr.


High molecular weight complex analysis of Epstein-Barr virus Latent Membrane Protein 1 (LMP-1): structural insights into LMP-1's homo-oligomerization and lipid raft association.

Wrobel CM, Geiger TR, Nix RN, Robitaille AM, Weigand S, Cervantes A, Gonzalez M, Martin JM.

Virus Res. 2013 Dec 26;178(2):314-27. doi: 10.1016/j.virusres.2013.09.025. Epub 2013 Sep 25.


NF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.

Ersing I, Bernhardt K, Gewurz BE.

Viruses. 2013 Jun 21;5(6):1587-606. doi: 10.3390/v5061587. Review.


The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.

Grunert M, Gottschalk K, Kapahnke J, Gündisch S, Kieser A, Jeremias I.

Cell Death Dis. 2012 Oct 25;3:e414. doi: 10.1038/cddis.2012.154.


Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter.

Lee EK, Chae JH, Kang MS.

Mol Cells. 2011 Dec;32(6):555-60. doi: 10.1007/s10059-011-0177-5. Epub 2011 Oct 19.


Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines.

Gupta S, Termini JM, Niu L, Kanagavelu SK, Rahmberg AR, Kornbluth RS, Evans DT, Stone GW.

Retrovirology. 2011 May 18;8:39. doi: 10.1186/1742-4690-8-39.


EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.

Gupta S, Termini JM, Niu L, Kanagavelu SK, Schmidtmayerova H, Snarsky V, Kornbluth RS, Stone GW.

J Leukoc Biol. 2011 Aug;90(2):389-98. doi: 10.1189/jlb.0211068. Epub 2011 May 17.


Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.

Boehm D, Gewurz BE, Kieff E, Cahir-McFarland E.

Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18103-8. doi: 10.1073/pnas.1011752107. Epub 2010 Oct 5.


Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation.

Trompouki E, Tsagaratou A, Kosmidis SK, Dollé P, Qian J, Kontoyiannis DL, Cardoso WV, Mosialos G.

Neoplasia. 2009 May;11(5):469-76.


Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.

Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M.

Nucleic Acids Res. 2008 Nov;36(20):6608-19. doi: 10.1093/nar/gkn666. Epub 2008 Oct 21.


Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis.

Hömig-Hölzel C, Hojer C, Rastelli J, Casola S, Strobl LJ, Müller W, Quintanilla-Martinez L, Gewies A, Ruland J, Rajewsky K, Zimber-Strobl U.

J Exp Med. 2008 Jun 9;205(6):1317-29. doi: 10.1084/jem.20080238. Epub 2008 May 19.


Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways.

Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC, Flemington EK.

J Virol. 2008 Feb;82(4):1946-58. Epub 2007 Dec 5.


EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.

Shair KH, Bendt KM, Edwards RH, Bedford EC, Nielsen JN, Raab-Traub N.

PLoS Pathog. 2007 Nov;3(11):e166.


The Edar subfamily in feather placode formation.

Drew CF, Lin CM, Jiang TX, Blunt G, Mou C, Chuong CM, Headon DJ.

Dev Biol. 2007 May 1;305(1):232-45. Epub 2007 Feb 16.


Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.

Rovedo M, Longnecker R.

J Virol. 2007 Jan;81(1):84-94. Epub 2006 Oct 11.


IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.

Song YJ, Jen KY, Soni V, Kieff E, Cahir-McFarland E.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2689-94. Epub 2006 Feb 13.


Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.

Panagopoulos D, Victoratos P, Alexiou M, Kollias G, Mosialos G.

J Virol. 2004 Dec;78(23):13253-61.


Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.

Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E.

J Virol. 2004 Apr;78(8):4108-19.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk